Drug
MHB018A injection
MHB018A injection is a pharmaceutical drug with 4 clinical trials. Currently 2 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(50%)
Phase Distribution
Ph phase_3
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
4(100.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(4)
Detailed Status
Recruiting2
Not yet recruiting2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 34 (100.0%)
Trials by Status
recruiting250%
not_yet_recruiting250%
Recent Activity
2 active trials
Showing 4 of 4
not_yet_recruitingphase_3
Open-Label Extension Study of MHB018A in Patients With Thyroid Eye Disease
NCT07620405
not_yet_recruitingphase_3
Treatment of Chronic Thyroid Eye Disease With MHB018A
NCT07622121
recruitingphase_3
MHB018A Treatment in Patients With Chronic Thyroid Eye Disease
NCT07257185
recruitingphase_3
Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease
NCT07262476
Clinical Trials (4)
Showing 4 of 4 trials
NCT07620405Phase 3
Open-Label Extension Study of MHB018A in Patients With Thyroid Eye Disease
NCT07622121Phase 3
Treatment of Chronic Thyroid Eye Disease With MHB018A
NCT07257185Phase 3
MHB018A Treatment in Patients With Chronic Thyroid Eye Disease
NCT07262476Phase 3
Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4